Abstract 10759: Atp Citrate Lyase: An Attractive Target at the Nexus of Metabolic and Epigenetic Alterations in Pulmonary Arterial Hypertension
Charlotte Romanet(Canadian Heart Research Centre), Sébastien Bonnet(Institut universitaire de cardiologie et de pneumologie de Québec), Sarah‐Eve Lemay(SNC-Lavalin (Canada)), Tsukasa Shimauchi(Kyushu University), Olivier Boucherat, Valérie Nadeau, Sandra Breuils Bonnet(Université Laval), Yann Grobs(Institut universitaire de cardiologie et de pneumologie de Québec), Alice Bourgeois, Steeve Provencher(Institut universitaire de cardiologie et de pneumologie de Québec)
Cited by 0
Related Papers
A Mitochondria-K+ Channel Axis Is Suppressed in Cancer and Its Normalization Promotes Apoptosis and Inhibits Cancer Growth
|Cancer Cell|2007|1.5k
Defining the clinical validity of genes reported to cause pulmonary arterial hypertension
|Genetics in Medicine|2023|73
TRPC3-Nox2 complex mediates doxorubicin-induced myocardial atrophy
|JCI Insight|2017|66
Oxidized DNA Precursors Cleanup by NUDT1 Contributes to Vascular Remodeling in Pulmonary Arterial Hypertension
|American Journal of Respiratory and Critical Care Medicine|2020|34
ATP citrate lyase drives vascular remodeling in systemic and pulmonary vascular diseases through metabolic and epigenetic changes
|Science Translational Medicine|2024|33